Sarentis Therapeutics Inc — Form D
Sarentis Therapeutics Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-08. The offering totals $1.0M, of which $750K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-07-08
- Form: D
- Accession: 0001477584-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $750K
- Remaining: $250K
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2015-06-24
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-243210
Issuer
- Name: Sarentis Therapeutics Inc
- CIK: 0001477584
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 70 E 77TH ST APT 9C, NEW YORK, NY, 10021
- Phone: (212) 861-6348
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Denise Barbut | Director | Philadelphia, PA |
| Denise Barbut | Executive Officer | Philadelphia, PA |
| Denise Barbut | Promoter | Philadelphia, PA |
Other filings by this issuer (1)
More